Layer, Chiang, et al. Genome Biology
NanoString Courting Early-Access Customers for New Copy Number Variation Assays
The CNV assays are the latest effort by NanoString to ferret out new applications for its nCounter platform, which the company initially developed as an alternative to both qPCR and microarrays for gene expression studies.
New to GenomeWeb? Register here quickly.